LBP AM SA

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1970075 Paris, I0

Position in BMRN

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$219,667

+$16,642 QoQ

Shares Held

3,839

+6.8% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#414

of 561 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

LBP AM SA holds $68,103,102 across 9 Biotechnology names. BMRN ranks #9 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BNTX	BioNTech SE	388,498	$36,149,738
2	INCY	Incyte Corp	95,697	$10,848,211
3	VRTX	Vertex Pharmaceuticals Inc / Ma	15,597	$7,747,497
4	ALNY	Alnylam Pharmaceuticals, Inc.	14,206	$4,276,432
5	VKTX	Viking Therapeutics, Inc.	93,906	$3,663,273
6	KYMR	Kymera Therapeutics, Inc.	17,947	$2,057,982
7	REGN	Regeneron Pharmaceuticals, Inc.	3,005	$1,873,737
8	RPRX	Royalty Pharma plc	22,589	$1,266,565

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$219,667	3,839	+6.8%	Shares	Defined	2026-07-24
2026-03-31	$203,025	3,594	-67.6%	Shares	Defined	2026-04-27
2025-09-30	$600,146	11,081	-2.4%	Shares	Defined	2025-10-31
2025-06-30	$624,403	11,359	-5.5%	Shares	Defined	2025-07-18
2025-03-31	$850,046	12,025	+120.7%	Shares	Defined	2025-04-30
2024-12-31	$358,162	5,449	-67.3%	Shares	Defined	2025-02-10
2024-09-30	$1,172,858	16,686	+49.4%	Shares	Defined	2024-11-12
2024-06-30	$919,543	11,169	+11.1%	Shares	Sole	2024-07-31
2024-03-31	$877,941	10,052	-95.7%	Shares	Sole	2024-05-16
2023-12-31	$22,707,102	235,502	0.0%	Shares	Sole	2024-02-14
2023-09-30	$20,837,216	235,502	-0.3%	Shares	Sole	2023-11-14
2023-06-30	$20,476,763	236,234	+5.2%	Shares	Sole	2023-08-14
2023-03-31	$21,842,923	224,629	-11.6%	Shares	Sole	2023-05-15
2022-12-31	$26,304,363	254,173	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.